Efficacy and Safety of Ponesimod Compared with Teriflunomide in Female Patients with Relapsing Multiple Sclerosis: Findings from the Pivotal OPTIMUM Study-Reference-Cited by-同舟云学术

Efficacy and Safety of Ponesimod Compared with Teriflunomide in Female Patients with Relapsing Multiple Sclerosis: Findings from the Pivotal OPTIMUM Study

Published:2024-04-01 Issue:4 Volume:33 Page:480-490
ISSN:1540-9996
Container-title:Journal of Women's Health
language:en
Short-container-title:Journal of Women's Health

Author:

Jones Robyn R.¹,Turkoz Ibrahim²,Ait-Tihyaty Maria³^ORCID,DiBernardo Allitia³,Houtchens Maria K.⁴,Havrdová Eva Kubala⁵

Affiliation:

1. Office of Chief Medical Officer, Johnson & Johnson, New Brunswick, New Jersey, USA.

2. Department of Statistics and Decision Sciences, Janssen Research & Development, LLC, Titusville, New Jersey, USA.

3. Global Medical Affairs, Janssen Research & Development, LLC, Titusville, New Jersey, USA.

4. Department of Neurology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.

5. Department of Neurology, First Medical Faculty, Charles University, Prague, Czech Republic.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/jwh.2023.0037

Reference31 articles.

1. Let’s talk about sex: Differences in drug therapy in males and females

2. Racial and Ethnic Disparities in Multiple Sclerosis Prevalence

3. The prevalence of MS in the United States

4. The nature of genetic and environmental susceptibility to multiple sclerosis

5. Female Gender and Reproductive Factors Affecting Risk, Relapses and Progression in Multiple Sclerosis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell trafficking in human chronic inflammatory diseases;iScience;2024-08